LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 192 filers reported holding LEGEND BIOTECH CORP in Q2 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,852,927 | -12.1% | 384,888 | -9.7% | 0.01% | -7.1% |
| Q2 2023 | $29,428,042 | +43.8% | 426,308 | +0.5% | 0.01% | +40.0% |
| Q1 2023 | $20,463,217 | -8.7% | 424,372 | -5.5% | 0.01% | -16.7% |
| Q4 2022 | $22,405,893 | +22.4% | 448,836 | +0.0% | 0.01% | +20.0% |
| Q3 2022 | $18,304,000 | -25.8% | 448,631 | 0.0% | 0.01% | -16.7% |
| Q2 2022 | $24,674,000 | +51.5% | 448,631 | +0.1% | 0.01% | +71.4% |
| Q1 2022 | $16,288,000 | -22.0% | 448,216 | 0.0% | 0.01% | -12.5% |
| Q4 2021 | $20,891,000 | -7.8% | 448,216 | 0.0% | 0.01% | -11.1% |
| Q3 2021 | $22,662,000 | +11.1% | 448,216 | -9.8% | 0.01% | +12.5% |
| Q2 2021 | $20,398,000 | +41.5% | 496,911 | 0.0% | 0.01% | +33.3% |
| Q1 2021 | $14,420,000 | -39.2% | 496,911 | -41.0% | 0.01% | -40.0% |
| Q4 2020 | $23,711,000 | -25.3% | 841,997 | -18.1% | 0.01% | -33.3% |
| Q3 2020 | $31,738,000 | +78.8% | 1,028,116 | +109.7% | 0.02% | +66.7% |
| Q2 2020 | $17,747,000 | – | 490,256 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 1,629,173 | $89,605,000 | 22.89% |
| Paradigm Biocapital Advisors LP | 978,596 | $53,823,000 | 10.73% |
| FengHe Fund Management Pte. Ltd. | 475,263 | $26,139,000 | 10.25% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,222,342 | $67,229,000 | 9.65% |
| HHLR ADVISORS, LTD. | 4,436,617 | $244,014,000 | 5.23% |
| Iron Triangle Partners LP | 495,329 | $27,243,000 | 3.53% |
| Parkman Healthcare Partners LLC | 117,807 | $6,479,000 | 2.39% |
| AtonRa Partners | 28,172 | $1,549,000 | 1.42% |
| Vivo Capital, LLC | 244,375 | $13,441,000 | 1.35% |
| Avidity Partners Management LP | 1,000,000 | $55,000,000 | 1.26% |